Gottlieb Looks Like Good Fit At FDA Helm To Supplement Industry
This article was originally published in The Rose Sheet
Executive Summary
Scott Gottlieb’s two stints at FDA and his support for limiting regulation that impedes innovation bode well for a supplement industry anxious for guidance on NDI notifications that aligns more with its expectation for less burdensome requirements than those the agency has stated.